Skip to content
Review Open access

Human cardiac organoids: multidimensional integration and clinical translation potential

Jul 2026 · Frontiers in Pharmacology · Vol 17 · 0 citations · 68 references
Medicine

TL;DR

This article adopts a multi-dimensional integration perspective to systematically summarize innovative breakthroughs in the construction of cardiac organoids through intelligent biomanufacturing, neuro-vascular-immune co-construction, and single-cell omics.

Abstract

Human cardiac organoids are important *in vitro* models for cardiovascular disease research, drug screening, and regenerative medicine. Unlike traditional reviews that focus on single technological advances, this article adopts a multi-dimensional integration perspective to systematically summarize innovative breakthroughs in the construction of cardiac organoids through intelligent biomanufacturing, neuro-vascular-immune co-construction, and single-cell omics. On this basis, we analyze the unique value of the integrated human-derived three-dimensional models in revealing novel disease mechanisms, and evaluate their current application status in personalized drug toxicity prediction and cardiac regeneration and repair. Through an interdisciplinary integration perspective, this review provides a theoretical framework and practical reference for advancing cardiac organoids from basic research toward clinical practice.

Read PDF

Similar papers

Review Open access Aug 2026

Advances in organoids for personalized medicine: from technological development to clinical application

Organoids, three-dimensional cell culture models derived from patient tissues or stem cells, have emerged as a cutting-edge technology in personalized medicine, owing to their remarkable ability to closely recapitulate in vivo tissue architecture and function. This review provides a comprehensive overview of the techno...

Xin-Kui Zhou, Xing-Xue Yan, Zheng-Yang Zhang et al. · 0 citations
Review Open access Sep 2026

Human cardiovascular organoids: Biomedical applications and ethical challenges

Cardiovascular disease (CVD) remains the leading cause of global mortality, yet traditional in vitro and animal models often fail to recapitulate the integrated structural, cellular, and functional complexity of the human heart. Recent advances in human pluripotent stem cell technology, developmental bioengineering, an...

Koushik Sen, Suravi Majumder, Dragana Stanišić et al. · 0 citations
Review Open access Sep 2026

Advances and Prospects of Cardiac Organoids in Drug Development

Cardiovascular diseases (CVDs) are the leading cause of death globally, propelling the urgent need for more effective drug development strategies. Traditional methods, such as two-dimensional (2D) cell cultures and animal models, fall short due to their limited structural complexity, lack of physiological relevance, an...

Xiao-Ying Liu, Ying-Juan Liu, Yu-Tong Yan et al. · 0 citations
Review Sep 2026

Next-generation brain organoids: neural complexity from cellular diversity to functional networks.

Brain organoids, as pioneering three-dimensional (3D) in vitro platforms, have profoundly advanced our understanding of human brain development and disease mechanisms. This review summarizes recent progress in enhancing cellular diversity, structural organization, and functional complexity within brain organoids. A key...

Chun-Hui Duan, Yu-Kai Wang, Tie-Shan Tang et al. · 0 citations
Review Open access Sep 2026

Organoids in precision medicine: the rise of miniature tissue models in research

Recent advances in biomedical research have increased demand for experimental systems capable of capturing human biological processes with greater physiological relevance than traditional approaches. However, direct investigation of cellular dynamics remains constrained by the invasive nature of many methodologies, t...

Maddalena Paganucci · 0 citations
Aug 2026

Function-First Organoid Engineering for Regenerative Medicine: Current Challenges and Future Perspectives.

A function-first framework in which regenerative organoids are engineered and evaluated according to measurable therapeutic outcomes, including tissue-specific function, vascular integration, immune compatibility, reproducibility, scalability, and long-term stability is proposed.

Yusuke Nishimura · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.